phytotherapy research : ptr

Plant disease

australasian psychiatry : bulletin of royal australian and new zealand college of psychiatrists

ACS omega

BMJ open

International journal of environmental research and public health

medicine and science in sports and exercise

Drug and alcohol dependence

accident; analysis and prevention

british journal of pharmacology

Plants (Basel, Switzerland)

addiction (abingdon, england)

Health technology assessment (Winchester, England)

Cureus

medicines (basel, switzerland)

phytochemical analysis : pca

The International journal on drug policy

addictive behaviors

epigenetics

canadian journal of diabetes

substance abuse treatment, prevention, and policy

revista brasileira de enfermagem

mayo clinic proceedings

substance use & misuse

Horticulture research

schizophrenia bulletin

sexual medicine reviews

bioscience

american journal of law & medicine

journal of psychoactive drugs

journal of oncology practice

european neuropsychopharmacology : the journal of the european college of neuropsychopharmacology

molecular cancer therapeutics

public opinion quarterly

Clinical & experimental ophthalmology

[1] Effects of Cannabinoids on Female Sexual Function.

[2] Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand?

[3] Charismatic leadership among nursing professionals: an integrative review.

[4] Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016.

[5] Frequently asked questions about dabbing concentrates in online cannabis community discussion forums.

[6] Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017.

[7] Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis.

[8] Cannabis use in older drivers in Colorado: The LongROAD Study.

[9] Patient Navigation in Cancer: The Business Case to Support Clinical Needs.

[10] Violence and self-harm in severe mental illness: inpatient study of associations with ethnicity, cannabis and alcohol.

[11] Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study.

[12] Prevalence and correlates of cannabis poisoning diagnosis in a national emergency department sample.

[13] Quantitative biochemical screening for marijuana use and concordance with tobacco use in urban adolescents.

[14] Admission Braden Skin Score Independently Predicts Mortality in Cardiac Intensive Care Patients.

[15] Ibrutinib potentiates anti-hepatocarcinogenic efficacy of sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma.

[16] The Public Health Concerns of Marijuana Legalization: An Overview of Current Trends.

[17] Presidential Address: The Need for Public Opinion Research Advocacy.

[18] Nobody Knew How Complicated: Constraining The President's Power To (Re)Shape Health Reform.

[19] Factors associated with cannabis use change in youth: Evidence from the COMPASS study.

[20] Highly Predictive Genetic Markers Distinguish Drug-Type from Fiber-Type L.

[21] U.S. cannabis legalization and use of vaping and edible products among youth.

[22] High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization.

[23] Anytime is the Right Time: A Content Analysis of Marijuana Ads in Freely Distributed Print Media in Western Washington State, USA.

[24] Cannabis Use and Stressful Life Events during the Perinatal Period: Cross-sectional Results from Pregnancy Risk Assessment Monitoring System (PRAMS) Data, 2016.

[25] Gender Norms, Roles and Relations and Cannabis-Use Patterns: A Scoping Review.

[26] Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study.

[27] The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms.

[28] Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review

[29] el consumo de drogas en el alumnado de la universidad de jaén

[30] grass is not always greener: rodenticide exposure of a threatened species near marijuana growing operations

[31] poorer frontolimbic white matter integrity is associated with chronic cannabis use, faah genotype, and increased depressive and apathy symptoms in adolescents and young adults

[32] support for marijuana (cannabis) legalization: untangling age, period, and cohort effects

[33] validation of the marijuana effect expectancies questionnaire (meeq) in a non-clinical french-speaking adolescent sample

[34] gender-specific associations between involvement in team sport culture and canadian adolescents’ substance-use behavior

[35] marijuana: current concepts

[36] the endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder

[37] do placebo response rates from cessation trials inform on strength of addictions?

[38] cannabis use in early adolescence: evidence of amygdala hypersensitivity to signals of threat

[39] corrigendum: an fmri study of neuronal activation in schizophrenia patients with and without previous cannabis use

[40] gone to pot - a review of the association between cannabis and psychosis

[41] Simple polymerase chain reaction assay to differentiate between fungal and Pythium insidiosum keratitis.

[42] A systematic analysis of apple root resistance traits to Pythium ultimum infection and the underpinned molecular regulations of defense activation.

[43] ADHD and Cannabis Use in College Students: Examining Indirect Effects of Coping Motives.

[44] Antioxidant activity and evidence for synergism of Cannabis sativa (L.)essential oil with antimicrobial standards

[45] Probing the antioxidant activity of Δ-tetrahydrocannabinol and cannabidiol in Cannabis sativa extracts.

[46] Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada

[47] Diabetes Canada Position Statement on Recreational Cannabis Use in Adults and Adolescents With Type 1 and Type 2 Diabetes

[48] Postmodernity, addictive societies, cannabis and suicidal behaviour: Towards a brave new world?

[49] Relationships between Problematic Cannabis Use and Risky Behaviors in Spanish Adolescents.

[50] Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DNA methylation in sperm.

[51] Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination.

[52] Cannabis Concentrate Use in Adolescents.

[53] Legalisation of non-medical cannabis in Canada: will supply regulations effectively serve public health?

[54] Cannabis use and leisure-time sedentary behavior among 94,035 adolescents aged 12-15 years from 24 low- and middle-income countries.

[55] Prospective Analysis of Prevalence, Trajectories of Change, and Correlates of Cannabis Misuse in Older Adolescents from Coastal Touristic Regions in Croatia.

[56] A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.

[57] The influence of cannabis smoke and cannabis vapour on simulated lung surfactant function under physiologically relevant conditions

[58] Genomic characterization of the complete terpene synthase gene family from Cannabis sativa.

[59] Patterns of cigarette, e-cigarette, and cannabis use among adult smokers in primary care 2014-2015.

[60] Cannabis, Decision-Making, and Online Assistance Seeking.

[61] Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016.

[62] Frequently asked questions about dabbing concentrates in online cannabis community discussion forums.

[63] Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis.

[64] New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum?

[65] Cannabis use in older drivers in Colorado: The LongROAD Study.

[66] Can Metal-Organic Frameworks Be Used for Cannabis Breathalyzers?

[67] Violence and self-harm in severe mental illness: inpatient study of associations with ethnicity, cannabis and alcohol.

[68] Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.

[69] Alcohol use disorder and cannabis use disorder symptomatology in adolescents are differentially related to dysfunction in brain regions supporting face processing

[70] Prevalence and correlates of cannabis poisoning diagnosis in a national emergency department sample.

[71] Cannabis and youth protection in Colorado's commercial adult-use market: A qualitative investigation

[72] Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance.

[73] [Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling].

[74] Has the “M” word been framed? Marijuana, cannabis, and public opinion

[75] Cannabis and amphetamine use and its psychosocial correlates among school-going adolescents in Ghana.

[76] Factors associated with cannabis use change in youth: Evidence from the COMPASS study.

[77] Aerosol Gas-Phase Components from Cannabis E-Cigarettes and Dabbing: Mechanistic Insight and Quantitative Risk Analysis.

[78] U.S. cannabis legalization and use of vaping and edible products among youth.

[79] American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019

[80] Erratum to “Short communication: Genetic association between schizophrenia and cannabis use” [Drug and Alcohol Dependence 171 (2017) 117–121](S0376871616309292)(10.1016/j.drugalcdep.2016.09.022)

[81] Characterising KandyPens-related posts to Instagram: implications for nicotine and cannabis use.

[82] Depressive symptoms moderate cannabis use for young adults in a Text-Delivered randomized clinical trial for cannabis use disorder

[83] Cannabis Use and Stressful Life Events during the Perinatal Period: Cross-sectional Results from Pregnancy Risk Assessment Monitoring System (PRAMS) Data, 2016.

[84] Gender Norms, Roles and Relations and Cannabis-Use Patterns: A Scoping Review.

[85] "You have to make some money before you can do some good": Balancing the commercial, social and public health objectives in a "community enterprise" regulatory model for alcohol and cannabis.

[86] Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study.

[87] The impact of peers and social disapproval on high-risk cannabis use: Gender differences and implications for drug education

[88] The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms.

[89] Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?

[90] Simultaneous bilateral spontaneous pneumomediastinum and pneumothorax in a cannabis user

[91] Assessing New Zealand's Cannabis Legalization and Control Bill: prospects and challenges.

[92] challenging the “inoffensiveness” of regular cannabis use by its associations with other current risky substance use—a census of 20-year-old swiss men

[93] Genetic structure and diversity of Iranian Cannabis populations based on phytochemical, agro-morphological and molecular markers

[94] cannabis and breastfeeding

[95] poorer frontolimbic white matter integrity is associated with chronic cannabis use, faah genotype, and increased depressive and apathy symptoms in adolescents and young adults

[96] toxic effects of cannabis and cannabinoids: animal data

[97] herpes simplex virus bronchiolitis in a cannabis user

[98] support for marijuana (cannabis) legalization: untangling age, period, and cohort effects

[99] addison’s disease and possible cannabis withdrawal syndrome presenting as an eating disorder in a thirty-year-old female

[100] tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke

[101] cannabis: evolution and ethnobotany. edited by robert c. clarke and mark d. merlin. 2013. university of california press, berkeley. 456 pp. $95.00 (hardcover). isbn 978-0- 520-27048-0.